Cargando…
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
INTRODUCTION: Genomic sequencing has rapidly transitioned into clinical practice, improving diagnosis and treatment options for patients with hereditary disorders. However, large-scale implementation of genomic sequencing faces challenges, especially with regard to the return of incidental results,...
Autores principales: | Shickh, Salma, Clausen, Marc, Mighton, Chloe, Gutierrez Salazar, Mariana, Zakoor, Kathleen-Rose, Kodida, Rita, Reble, Emma, Elser, Christine, Eisen, Andrea, Panchal, Seema, Aronson, Melyssa, Graham, Tracy, Armel, Susan Randall, Morel, Chantal F, Fattouh, Ramzi, Glogowski, Emily, Schrader, Kasmintan A, Hamilton, Jada G, Offit, Kenneth, Robson, Mark, Carroll, June C, Isaranuwatchai, Wanrudee, Kim, Raymond H, Lerner-Ellis, Jordan, Thorpe, Kevin E, Laupacis, Andreas, Bombard, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797333/ https://www.ncbi.nlm.nih.gov/pubmed/31594892 http://dx.doi.org/10.1136/bmjopen-2019-031092 |
Ejemplares similares
-
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial
por: Shickh, Salma, et al.
Publicado: (2018) -
Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery
por: Shickh, Salma, et al.
Publicado: (2022) -
Quality of life drives patients’ preferences for secondary findings from genomic sequencing
por: Mighton, Chloe, et al.
Publicado: (2020) -
From the patient to the population: Use of genomics for population screening
por: Mighton, Chloe, et al.
Publicado: (2022) -
“Game Changer”: Health Professionals’ Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management
por: Shickh, Salma, et al.
Publicado: (2022)